Cardio3 BioSciences SA of Belgium said that its previously announced European initial public offering of shares has raised €23 million from investors in Belgium, France, the UK, the Netherlands, Scandinavia and the US. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
